朝日ゲノミクス
  • EnglishEnglish
    • 日本語日本語
    • EnglishEnglish
  • Company Profile

Posted in The Nikkei Newspaper Article (Febraury 21, 2017)

Posted on 2017年2月27日2017年3月22日 by ascendadmin

Professors Seiji Ogawa of Kyoto University and others have developed technology to predict the effectiveness of Opivalvo.

This entry was posted in Uncategorized. Bookmark the permalink.

Post navigation

← Princess Takamatsu Cancer Research Fund
Posted in The Nikkei Newspaper Article (December 21, 2016) →

Latest News

  • 2018 Medal with Purple Ribbon
  • Posted in The Bungeishunju Article (April 10, 2018)
  • Takeda Prize for Medical Science
  • Posted in The Nikkei Newspaper Article (August 22, 2017)
  • Posted in The Nikkei Bio Tech Article (June 12, 2017)

Categories

  • Uncategorized
8th Flr., Kojimachi Miyuki Bldg., 3-4 Niban-cho, Chiyoda Ward, Tokyo
+81-3-6261-3803

Copyright Asahi Genomics Co., Ltd.
Designed by Freepik